"The global regenerative medicine markets comprise of many key market players competing for markets shares like Novartis AG (Switzerland), Biogen, Inc. (US), Sarepta Therapeutics, Inc.

According to Acumen Research and Consulting, the global Personalized Medicine Biomarkers Market was valued at USD 20.95 billion in 2024 and is projected to reach USD 72.06 billion by 2033, growing at ...